Beyond the Numbers: Every Data Point Tells a Different Story
While data and cost are important elements in recognizing issues, the measure of success isn’t just about the data or the numbers; it’s about ensuring that older adults can manage and maintain their expectations about health and aging in place.
Auxira Health Secures $7.8M for Virtual Cardiology Platform
Auxira Health's $7.8 million round was led by Route 66 Ventures and Abundant Venture Partners and included participation from DigiTx Partners, American Heart Association Ventures, Ensemble Innovation Ventures and City Light Capital.
Hundred Health Emerges from Stealth to Turn Health Data into Daily Action
Hundred Health emerged from stealth with an app that pulls together users’ medical records, lab results, wearable data and lifestyle information to create personalized, evidence-based 100-day health plans.
How Precision Medicine and AI are Evolving: An MD Anderson Perspective
Dr. Prajnan Das, department chair of Gastrointestinal (GI) Radiation Oncology at MD Anderson Cancer Center, talks about how precision medicine has evolved and how AI may actually be the technology that supercharges the conversion of the knowledge about human biology to personalized treatments that work.
AstraZeneca, Daiichi Sankyo ADC Enhertu Moves Up to First-Line Use in Breast Cancer
FDA approval for Enhertu as a first-line breast cancer treatment is important because many patients with HER2-positive cancer do not live long enough to receive a second line of therapy. In Enhertu’s pivotal study in this setting, the HER2-targeting ADC helped patients live more than three years without disease progression or death.